Mr. Kevin Hennegan is the Senior Managing Consultant for CBR. Mr. Hennegan has been involved in the biopharmaceutical industry since 2001 and spent three years in Research & Development for a biotechnology company in northern California before joining CBR in 2004.

As part of his responsibilities at CBR, he provides clients with strategic product development and regulatory recommendations. He has participated in the development of Quality Systems, provided oversight for Quality Assurance and Quality Control departments, and assisted with hosting FDA Inspections for a number of biotechnology and pharmaceutical companies. He is an experienced medical writer, having contributed to a number of clinical study reports, authored clinical study protocols, and lead the preparation of a briefing document for an FDA Advisory Committee. Mr. Hennegan is a skilled auditor, providing sponsors with assessments of their Quality Systems, cGCPs and cGMPs. He is responsible for several regulatory programs and has served as the US Authorized Representative to the FDA for CBR’s clients. He is also a member of the CBR management team, providing guidance and oversight to CBR’s consultants, associates and affiliates.

Mr. Hennegan received a M.A. in Molecular, Cellular and Developmental Biology from the University of Colorado at Boulder and a B.S. in Microbiology from Colorado State University.

Consistent, thorough and up-to-date analysis of your evolving needs is just the beginning of our commitment to your program. For a comprehensive assessment of your program requirements, please contact us by calling (720) 746-1190 or by email at info@cbrintl.com.
.